HAPPE Spine announced the addition of two more issued patents in a growing portfolio of orthopedic and spinal implants enabled by the HAPPE™ (HydroxyApatite Porous PolyEtheretherketone) platform. The HAPPE material platform offers interconnected, cancellous porosity and bioactive surfaces with exposed hydroxyapatite to enable robust bone in-growth and on-growth confirmed in preclinical testing.
U.S. Patent Number 11,179,243 protects implantable devices such as interbody spinal fusion cages that are constructed with a thermoplastic polymer such as polyetheretherketone, at least one region with interconnected porosity, and bioactive particles such as hydroxyapatite integrated in the polymer and exposed on pore surfaces to encourage bone ingrowth.
U.S. Patent Number 11,426,904 protects a process for forming implants from thermoplastic polymers with regions of differing porosity. Unlike additive manufacturing of PEEK implants, the process enables molding of monolithic implants from powder-based raw materials such that there are no seams, joints or bonds in the implant, but rather a continuous polymer matrix between regions of relatively porous and dense material.
HAPPE’s orthopedic material platform, HydroxyApatite Porous PEek (HAPPE), transforms polyetheretherketone (PEEK) from a hydrophobic, bioinert and non-integrating material into a hydrophilic, bioactive and osteointegrating material. As such, the HAPPE material platform promises to improve clinical outcomes in spinal fusion by augmenting the radiolucency, bone-like mechanical properties and subsidence resistance of conventional PEEK with designed cancellous porosity and bioactive surfaces for osteointegration.
HAPPE Spine announced the addition of two more issued patents in a growing portfolio of orthopedic and spinal implants enabled by the HAPPE™ (HydroxyApatite Porous PolyEtheretherketone) platform. The HAPPE material platform offers interconnected, cancellous porosity and bioactive surfaces with exposed hydroxyapatite to enable robust bone...
HAPPE Spine announced the addition of two more issued patents in a growing portfolio of orthopedic and spinal implants enabled by the HAPPE™ (HydroxyApatite Porous PolyEtheretherketone) platform. The HAPPE material platform offers interconnected, cancellous porosity and bioactive surfaces with exposed hydroxyapatite to enable robust bone in-growth and on-growth confirmed in preclinical testing.
U.S. Patent Number 11,179,243 protects implantable devices such as interbody spinal fusion cages that are constructed with a thermoplastic polymer such as polyetheretherketone, at least one region with interconnected porosity, and bioactive particles such as hydroxyapatite integrated in the polymer and exposed on pore surfaces to encourage bone ingrowth.
U.S. Patent Number 11,426,904 protects a process for forming implants from thermoplastic polymers with regions of differing porosity. Unlike additive manufacturing of PEEK implants, the process enables molding of monolithic implants from powder-based raw materials such that there are no seams, joints or bonds in the implant, but rather a continuous polymer matrix between regions of relatively porous and dense material.
HAPPE’s orthopedic material platform, HydroxyApatite Porous PEek (HAPPE), transforms polyetheretherketone (PEEK) from a hydrophobic, bioinert and non-integrating material into a hydrophilic, bioactive and osteointegrating material. As such, the HAPPE material platform promises to improve clinical outcomes in spinal fusion by augmenting the radiolucency, bone-like mechanical properties and subsidence resistance of conventional PEEK with designed cancellous porosity and bioactive surfaces for osteointegration.
Copy to clipboard 
